Clinical trial supply chains now span biologics, cell and gene therapies, adaptive protocols, and decentralized sites worldwide. In this environment, visibility alone does not suffice. Protecting timelines and patient access requires sponsors to anticipate risk and act before issues arise. Intelligence platforms now unify fragmented data and apply predictive analytics to clinical supply chains. These systems enable teams to make faster, more informed decisions by providing actionable insights. This paper examines how the intelligence layer is changing clinical supply operations.